NasdaqCM:AEHR - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
5/31/2027	125	N/A	N/A	N/A	1
5/31/2026	92	N/A	N/A	N/A	1
5/31/2025	71	N/A	N/A	N/A	2
5/31/2024	66	33	1	2	N/A
2/29/2024	72	15	5	6	N/A
11/30/2023	82	21	6	8	N/A
8/31/2023	75	19	7	8	N/A
5/31/2023	65	15	9	10	N/A
2/28/2023	63	14	3	3	N/A
11/30/2022	61	12	1	2	N/A
8/31/2022	56	9	5	5	N/A
5/31/2022	51	9	1	2	N/A
2/28/2022	38	4	2	2	N/A
11/30/2021	28	1	5	5	N/A
8/31/2021	20	-1	-2	-1	N/A
5/31/2021	17	-2	-3	-3	N/A
2/28/2021	13	-5	-4	-4	N/A
11/30/2020	14	-4	-4	-4	N/A
8/31/2020	19	-2	-1	-1	N/A
5/31/2020	22	-3	-2	-2	N/A
2/29/2020	26	0	-2	-1	N/A
11/30/2019	23	-3	-3	-3	N/A
8/31/2019	22	-4	-5	-5	N/A
5/31/2019	21	-5	-6	-6	N/A
2/28/2019	21	-5	-3	-3	N/A
11/30/2018	25	-2	-3	-2	N/A
8/31/2018	27	-1	1	2	N/A
5/31/2018	30	1	-2	-1	N/A
2/28/2018	29	0	N/A	-3	N/A
11/30/2017	24	-3	N/A	-5	N/A
8/31/2017	21	-5	N/A	-10	N/A
5/31/2017	19	-6	N/A	-4	N/A
2/28/2017	14	-8	N/A	-6	N/A
11/30/2016	13	-8	N/A	-4	N/A
8/31/2016	13	-8	N/A	-3	N/A
5/31/2016	15	-7	N/A	-6	N/A
2/29/2016	15	-6	N/A	-5	N/A
11/30/2015	15	-4	N/A	-5	N/A
8/31/2015	13	-5	N/A	-4	N/A
5/31/2015	10	-7	N/A	-2	N/A
2/28/2015	14	-5	N/A	-2	N/A
11/30/2014	17	-3	N/A	-2	N/A
8/31/2014	19	0	N/A	-1	N/A
5/31/2014	20	0	N/A	-1	N/A
2/28/2014	18	-1	N/A	0	N/A
11/30/2013	15	-2	N/A	1	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van AEHR boven de spaarquote ( 2.5% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van AEHR naar verwachting sneller zal groeien dan de markt US

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van AEHR naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: De omzet van AEHR ( 21.1% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.7% per jaar).

Hoge groei-inkomsten: De omzet van AEHR ( 21.1% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van AEHR naar verwachting over 3 jaar hoog zal zijn

Aehr Test Systems Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 108% to US$25.00

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Provides Earnings Guidance for the Year 2024

Aehr Test Systems Reiterates Revenue Guidance for the Fiscal Year Ending May 31, 2023

Recent updates

Aehr Test Systems, Inc. to Report Q1, 2025 Results on Oct 10, 2024

Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024

Aehr Test Systems (NASDAQ:AEHR) Is Experiencing Growth In Returns On Capital

Investor sentiment deteriorates as stock falls 19%

Independent Director recently sold US$186k worth of stock

Price target increased by 108% to US$25.00

Full year 2024 earnings released: EPS: US$1.15 (vs US$0.52 in FY 2023)

Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.

Aehr Test Systems' (NASDAQ:AEHR) 27% Share Price Surge Not Quite Adding Up

Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.

Investor sentiment improves as stock rises 40%

Aehr Test Systems to Report Q4, 2024 Results on Jul 16, 2024

Now 23% overvalued

Investor sentiment deteriorates as stock falls 18%

Now 20% overvalued

New minor risk - Share price stability

Aehr Test Systems: The Bottom Might Be In

We Like These Underlying Return On Capital Trends At Aehr Test Systems (NASDAQ:AEHR)

Investor sentiment improves as stock rises 15%

Insufficient new directors

Why Aehr Test Systems (NASDAQ:AEHR) Could Be Worth Watching

Now 24% overvalued

Aehr Test Systems' (NASDAQ:AEHR) Solid Earnings May Rest On Weak Foundations

New major risk - Revenue and earnings growth

Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Some Confidence Is Lacking In Aehr Test Systems (NASDAQ:AEHR) As Shares Slide 30%

Investor sentiment deteriorates as stock falls 15%

Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024

Investor sentiment deteriorates as stock falls 16%

Investors Shouldn't Overlook Aehr Test Systems' (NASDAQ:AEHR) Impressive Returns On Capital

Aehr Test Systems Faces Cyclical Headwinds (Rating Downgrade)

Investor sentiment improves as stock rises 17%

Founder & Independent Chairman exercised options to buy US$310k worth of stock.

Should You Investigate Aehr Test Systems (NASDAQ:AEHR) At US$14.85?

President recently sold US$85k worth of stock

President notifies of intention to sell stock

Aehr Test Systems: Revised Guidance Likely To Be Lowered Again - Sell

Second quarter 2024 earnings released: EPS: US$0.21 (vs US$0.14 in 2Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems' (NASDAQ:AEHR) Shareholders Might Be Looking For Exit

Does Aehr Test Systems (NASDAQ:AEHR) Deserve A Spot On Your Watchlist?

Investor sentiment deteriorates as stock falls 22%

Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating Committee

Investor sentiment deteriorates as stock falls 21%

Aehr Test Systems (NASDAQ:AEHR) Is Very Good At Capital Allocation

First quarter 2024 earnings released: EPS: US$0.16 (vs US$0.022 in 1Q 2023)

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems to Report Q1, 2024 Results on Oct 05, 2023

Aehr Test Systems, Annual General Meeting, Oct 23, 2023

Calculating The Fair Value Of Aehr Test Systems (NASDAQ:AEHR)

Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)

Investor sentiment deteriorates as stock falls 18%

Here's Why We Think Aehr Test Systems (NASDAQ:AEHR) Might Deserve Your Attention Today

Independent Director notifies of intention to sell stock

Independent Director notifies of intention to sell stock

President recently sold US$6.3m worth of stock

President notifies of intention to sell stock

Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)

Aehr Test Systems Provides Earnings Guidance for the Year 2024

Aehr Test Systems to Report Q4, 2023 Results on Jul 13, 2023

The Return Trends At Aehr Test Systems (NASDAQ:AEHR) Look Promising

Is It Too Late To Consider Buying Aehr Test Systems (NASDAQ:AEHR)?

Investor sentiment improves as stock rises 23%

Aehr Test Systems Appoints Chris Siu as Executive Vice President of Finance and Secretary Effective June 1, 2023

Founder & Chairman notifies of intention to sell stock

Investor sentiment improves as stock rises 15%

Investors Interested In Aehr Test Systems' (NASDAQ:AEHR) Earnings

If EPS Growth Is Important To You, Aehr Test Systems (NASDAQ:AEHR) Presents An Opportunity